104 results on '"Palella Jr, Frank J."'
Search Results
2. Patterns of objectively measured physical activity differ between men living with and without HIV.
3. Incorporating Frailty Into the Pooled Cohort Equations to Predict Cardiovascular Disease Among Persons With HIV.
4. Aging, trends in CD4+/CD8+ cell ratio, and clinical outcomes with persistent HIV suppression in a dynamic cohort of ambulatory HIV patients.
5. Incorporating Frailty Into the Pooled Cohort Equations to Predict Cardiovascular Disease Among Persons With HIV.
6. US hospital care for patients with HIV infection and pneumonia *: the role of public, private, and veterans affairs hospitals in the early highly active antiretroviral therapy era
7. HIV viral exposure and mortality in a multicenter ambulatory HIV adult cohort, United States, 1995-2016.
8. The association of adipose tissue area with subclinical coronary atherosclerosis progression in men with and without HIV.
9. Carotid artery atherosclerosis is associated with mortality in HIV-positive women and men.
10. Aging-Related Comorbidity Burden Among Women and Men With or At-Risk for HIV in the US, 2008-2019.
11. Time spent with HIV viral load above 1500 copies/ml among patients in HIV care, 2000-2014.
12. Time Requirements for Acquisition of Hepatitis C Virus Therapy in HIV/HCV Coinfected Patients.
13. Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults.
14. Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected men
15. Disability Among Middle-Aged and Older Persons With Human Immunodeficiency Virus Infection.
16. Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver.
17. Clinical implications of aging with HIV infection: perspectives and the future medical care agenda.
18. The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus.
19. Changes in bone turnover markers with HIV seroconversion and ART initiation.
20. Frailty and Components of the Frailty Phenotype are Associated with Modifiable Risk Factors and Antiretroviral Therapy.
21. Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men With or at Risk for HIV Infection.
22. Glomerular filtration rate and proteinuria associations with coronary artery calcium among HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study.
23. Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.
24. Cardiovascular Disease Risk Prediction in the HIV Outpatient Study.
25. Associations between antiretroviral use and subclinical coronary atherosclerosis.
26. Cardiovascular disease risk scores' relationship to subclinical cardiovascular disease among HIV-infected and HIV-uninfected men.
27. Intestinal Microbiota-Produced Trimethylamine-N-Oxide and Its Association With Coronary Stenosis and HIV Serostatus.
28. Long-term impact of HIV wasting on physical function.
29. A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study.
30. Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men.
31. Antiretroviral Regimen Durability and Success in Treatment-Naive and Treatment-Experienced Patients by Year of Treatment Initiation, United States, 1996-2011.
32. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
33. Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men.
34. Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.
35. Long-term immunologic and virologic responses on raltegravir-containing regimens among ART-experienced participants in the HIV Outpatient Study.
36. Trends in use of genotypic resistance testing and frequency of major drug resistance among antiretroviral-naive persons in the HIV Outpatient Study, 1999-2011.
37. Elevated Levels of Monocyte Activation Markers Are Associated With Subclinical Atherosclerosis in Men With and Those Without HIV Infection.
38. The Association Between APOL1 Risk Alleles and Longitudinal Kidney Function Differs by HIV Viral Suppression Status.
39. Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters.
40. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS)
41. The Case for Earlier Treatment of HIV Infection
42. Anthropometrics and Examiner‐Reported Body Habitus Abnormalities in the Multicenter AIDS Cohort Study
43. ARTAIDSAMERICA: An Exhibit.
44. Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis.
45. Associations Between HIV Infection and Subclinical Coronary Atherosclerosis.
46. Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men.
47. Factors Affecting Glomerular Filtration Rate, as Measured by Iohexol Disappearance, in Men with or at Risk for HIV Infection.
48. HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection.
49. Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants.
50. Increases in Duration of First Highly Active Antiretroviral Therapy Over Time (1996-2009) and Associated Factors in the Multicenter AIDS Cohort Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.